Sessions to discuss clinical cases are held to improve the experts' knowledge about delaing with HIV-patients' resistances. Each case is discusses in a presential session with a reduced number od MDs and the experts Jonathan Schapiro y Bonaventura Clotet.
Supported by Janssen.
Mario Stevenson MD, from Masachussets' University, and other experts, offered their point of view about the possibility of erradicating HIV. This conference could be followed in life thanks to video-conference system, from Madrid, Valencia, Zaragoza or Bilbao, for example. You still can consult the videos of the speeches at www.flsida.org/eradication.
Supported by MSD.
Call-conferences on resistances are a kind of telephone clinical sessions addressing clinical cases on resistance to antiretroviral treatment.The cases are reviewed by three experts before the teleconference: Dr. Jonathan Schapiro (Stanford University), Dr. Santiago Moreno (Hospital Ramón y Cajal) and Dr. Bonaventura Clotet (Hospital Germans Trias). During the teleconference, the participants discuss the case and a decision is taken on a treatment proposal.
Call Conferences on resistances are organized by FLS and Fundació IrsiCaixa, and promoted by Glaxo Smithkline (GSK), Gilead, Janssen-Cilag Division Tibotec and Siemens.
Fundació Lluita contra la Sida and Fundació IrsiCaixa offer intensive two days lenght courses in which pharmaceutic industry professionals can have an "immersion" in the world of HIV. The aim of these courses is to offer them a trainig and an update in HIV infection that allow them to develop their job with an excellent knowledge of what is currently relevant about the illness and its treatment.
Clinical cases discussion sessions are prepared to improve specialists' knowledge about resistances handling in HIV patients. Each case is discussed in a presential session with a reduced number of MD and experts Jonathan Schapiro and Bonaventura Clotet.
Supported by Roche laboratories.
Summary of the Conference on Retroviruses and Opportunistic Infections (CROI), one of the most important conferences in the world in the field of HIV/aids, but specially aimed to people working or interested in HIV from the communitary area.
If you want further information or enter this activity, contact with Sonia Clemares, sclemares@flsida.org or 93 465 78 97. Inscription and transport to Barcelona are free.
The discussion of clinical cases about Tipranavir is raised as a space inspired in a clinical session with MD's that take care of HIV patients dayly whose resistances profile will determinate the treatment. MD suggests a not solved real case before the reunion in which the use of Tipranavir is being assessed. This case will be live discussed in a session with the rest of MD's, professor Carlo F. Perno and Bonaventura Clotet. Together, an agreement will be reached to recommend a treatment for each case.
Supported by Boehringer Ingelheim.
Call conferences are a kind of telephone clinical sessions addressing clinical cases on resistance to antiretroviral treatment (further information at TEACHING/PROJECTS)
With the experts: Schapiro MD, Arribas MD, Ribera MD, Moreno MD and Clotet MD
This course is aimed to professionals from the pharmaceutic industry who have recently started the development of tasks related to HIV field or who would like to update their knowledge on the subject, learning which are the outstanding aspects of the illness and its treatment nowadays.
The course length is 15 hours, divided in two days from 10 to 19 p.m.
For further information, download this file: HIV Intensive Update PDF
Download the inscription's form
(for further information see TEACHING-PROJECTS)
Conference: Professor Stefan Zeuzem, from the Department of Internal Medicine of the Saarland University Hospital, Deutschland. With the support of Roche Farma.
Chairmans: Bonaventura Clotet and Josep Maria Gatell.
Subjects and speakers:
Organizers: FLS (Fundació Lluita contra la Sida). With the suport of GSK (GlaxoSmithKline)
The main objective of the courses that are imparted in this STAGE FCI is to spread and stimulate the knowledge of the last advances in the treatment, research and prevention on HIV among professionals. We propose an intensive updating program about different interesting subjects in which we have been pioneers.
Barcelona, 14th September and Madrid, 15th September 2006. With the support of Roche.
Hospitals participating: Hospital Clínico de Valencia - Dra.Galindo, Hospital Ntra. Sra. De Aranzazu - Dr. Iribarren, Hospital Xeral de Vigo - Dr. Miralles and Dr. Ocampo, Hospital de Sant Pau- Dr. Domingo and Dr. Fuster, Hospital Parc Taulí (Sabadell) - Dr. Cervantes, Hospital Sant Jaume (Calella) - Dr. Llibre, Hospital Ramón y Cajal (Madrid) - Dr. Moreno, Hospital de Valladolid - Dr. Del Pozo, Hospital Universitari Trias i Pujol - Dr. Clotet, Hospital de Málaga - Dra. Viciana, Hospital de Zaragoza - Dra. Arazo.
With the participation of: Hospital de Palamós, Hospital Sant Jaume de Calella, Hospital de Mataró, Hospital de Granollers, Hospital de Sant Pau, Hospital General de Vic, Hospital Joan XXIII de Tarragona, Hospital Parc Taulí de Sabadell i Hospital Germans Trias i Pujol.
Six teleconferences took place during 2005, with a final meeting for conclusions at Madrid, on December. With the support of Glaxo SmithKline and Bayer Diagnostics.
With the participation of: Hospital Clínic de València, Hospital Donosti (Sant Sebastià), Hospital de Vigo, Hospital de Sant Pau (Barcelona), Hospital Parc Taulí (Sabadell), Hospital Sant Jaume (Calella), Hospital Ramón y Cajal (Madrid), Hospital XII de Octubre (Madrid), Hospital de Valladolid, Hospital Universitari Trias i Pujol (Barcelona), Hospital Clinico (Santiago Compostela), Hospital de Huelva
© FUNDACIÓ LLUITA CONTRA LA SIDA · Tots els drets reservats · Política de qualitat · Disseny i programació